nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—KCNJ11—type 1 diabetes mellitus	0.839	1	CbGaD
Levosimendan—KCNJ8—ATP sensitive Potassium channels—ABCC8—type 1 diabetes mellitus	0.0253	0.198	CbGpPWpGaD
Levosimendan—KCNJ8—ATP sensitive Potassium channels—KCNJ11—type 1 diabetes mellitus	0.02	0.157	CbGpPWpGaD
Levosimendan—KCNJ11—ATP sensitive Potassium channels—ABCC8—type 1 diabetes mellitus	0.012	0.0938	CbGpPWpGaD
Levosimendan—PDE3A—penis—type 1 diabetes mellitus	0.0111	0.334	CbGeAlD
Levosimendan—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—ITPR3—type 1 diabetes mellitus	0.00767	0.06	CbGpPWpGaD
Levosimendan—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—PRKCQ—type 1 diabetes mellitus	0.00541	0.0423	CbGpPWpGaD
Levosimendan—KCNJ8—Inwardly rectifying K+ channels—ABCC8—type 1 diabetes mellitus	0.00492	0.0385	CbGpPWpGaD
Levosimendan—KCNJ8—Inwardly rectifying K+ channels—KCNJ11—type 1 diabetes mellitus	0.00389	0.0304	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—INS-IGF2—type 1 diabetes mellitus	0.00376	0.0294	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—PDX1—type 1 diabetes mellitus	0.0032	0.025	CbGpPWpGaD
Levosimendan—KCNJ8—islet of Langerhans—type 1 diabetes mellitus	0.00308	0.0931	CbGeAlD
Levosimendan—TNNC1—cardiovascular system—type 1 diabetes mellitus	0.00297	0.0898	CbGeAlD
Levosimendan—KCNJ11—islet of Langerhans—type 1 diabetes mellitus	0.00251	0.0759	CbGeAlD
Levosimendan—KCNJ11—Inwardly rectifying K+ channels—ABCC8—type 1 diabetes mellitus	0.00233	0.0182	CbGpPWpGaD
Levosimendan—KCNJ8—cardiovascular system—type 1 diabetes mellitus	0.00223	0.0674	CbGeAlD
Levosimendan—KCNJ8—kidney—type 1 diabetes mellitus	0.00218	0.0659	CbGeAlD
Levosimendan—KCNJ8—pancreas—type 1 diabetes mellitus	0.00217	0.0655	CbGeAlD
Levosimendan—KCNJ8—Potassium Channels—ABCC8—type 1 diabetes mellitus	0.00194	0.0152	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—PDX1—type 1 diabetes mellitus	0.00184	0.0144	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—HNF1A—type 1 diabetes mellitus	0.00184	0.0144	CbGpPWpGaD
Levosimendan—KCNJ11—cardiovascular system—type 1 diabetes mellitus	0.00182	0.0549	CbGeAlD
Levosimendan—PDE3A—cardiovascular system—type 1 diabetes mellitus	0.00178	0.0538	CbGeAlD
Levosimendan—KCNJ11—pancreas—type 1 diabetes mellitus	0.00177	0.0534	CbGeAlD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ABCC8—type 1 diabetes mellitus	0.00176	0.0138	CbGpPWpGaD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS1—type 1 diabetes mellitus	0.00162	0.0127	CbGpPWpGaD
Levosimendan—KCNJ8—Potassium Channels—KCNJ11—type 1 diabetes mellitus	0.00154	0.012	CbGpPWpGaD
Levosimendan—KCNJ11—lymphoid tissue—type 1 diabetes mellitus	0.00153	0.0461	CbGeAlD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—IGFBP1—type 1 diabetes mellitus	0.00127	0.00996	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—ABCC8—type 1 diabetes mellitus	0.00113	0.0088	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.001	0.00785	CbGpPWpGaD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—type 1 diabetes mellitus	0.000966	0.00755	CbGpPWpGaD
Levosimendan—KCNJ11—Potassium Channels—ABCC8—type 1 diabetes mellitus	0.000921	0.0072	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—ABCC8—type 1 diabetes mellitus	0.000885	0.00692	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000849	0.00664	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—ITPR3—type 1 diabetes mellitus	0.000838	0.00655	CbGpPWpGaD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—type 1 diabetes mellitus	0.000776	0.00607	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—ITPR3—type 1 diabetes mellitus	0.000751	0.00587	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GAD2—type 1 diabetes mellitus	0.000742	0.0058	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000741	0.00579	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000671	0.00525	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00065	0.00508	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GAD1—type 1 diabetes mellitus	0.000643	0.00503	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS1—type 1 diabetes mellitus	0.000631	0.00493	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—ITPR3—type 1 diabetes mellitus	0.000591	0.00462	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—GCG—type 1 diabetes mellitus	0.00055	0.0043	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—IAPP—type 1 diabetes mellitus	0.000541	0.00423	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SIRPG—type 1 diabetes mellitus	0.000536	0.00419	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000528	0.00413	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—type 1 diabetes mellitus	0.000483	0.00378	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB1—type 1 diabetes mellitus	0.000473	0.0037	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—type 1 diabetes mellitus	0.000456	0.00356	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—type 1 diabetes mellitus	0.000443	0.00347	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—GCG—type 1 diabetes mellitus	0.000432	0.00338	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—GCG—type 1 diabetes mellitus	0.000424	0.00331	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000402	0.00314	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS2—type 1 diabetes mellitus	0.000376	0.00294	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GAD2—type 1 diabetes mellitus	0.000351	0.00275	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—INS—type 1 diabetes mellitus	0.000309	0.00242	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000308	0.00241	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GAD1—type 1 diabetes mellitus	0.000305	0.00238	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS3—type 1 diabetes mellitus	0.000302	0.00236	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000277	0.00216	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000276	0.00216	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—INS—type 1 diabetes mellitus	0.000243	0.0019	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SELL—type 1 diabetes mellitus	0.000239	0.00187	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000201	0.00157	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITPR3—type 1 diabetes mellitus	0.000188	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SH2B3—type 1 diabetes mellitus	0.000177	0.00138	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000162	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000142	0.00111	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS1—type 1 diabetes mellitus	0.000141	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000141	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.000132	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000132	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000129	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VAV1—type 1 diabetes mellitus	0.000129	0.001	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000128	0.000999	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000128	0.000999	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HBA2—type 1 diabetes mellitus	0.000124	0.000971	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00012	0.000939	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000119	0.000928	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—G6PC2—type 1 diabetes mellitus	0.000117	0.000913	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF2—type 1 diabetes mellitus	0.000116	0.00091	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000111	0.000868	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000108	0.000843	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCC8—type 1 diabetes mellitus	0.000101	0.000791	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000101	0.000788	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2RA—type 1 diabetes mellitus	9.8e-05	0.000766	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SST—type 1 diabetes mellitus	9.75e-05	0.000762	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	9.71e-05	0.000759	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SST—type 1 diabetes mellitus	8.85e-05	0.000692	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	8.81e-05	0.000689	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	8.69e-05	0.000679	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—type 1 diabetes mellitus	8.43e-05	0.000659	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	8.36e-05	0.000654	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	8.12e-05	0.000635	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	8.1e-05	0.000633	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GCG—type 1 diabetes mellitus	7.89e-05	0.000617	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAL—type 1 diabetes mellitus	7.63e-05	0.000597	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	7.6e-05	0.000594	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL20—type 1 diabetes mellitus	7.55e-05	0.00059	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL11—type 1 diabetes mellitus	7.55e-05	0.00059	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—type 1 diabetes mellitus	7.47e-05	0.000584	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	7.38e-05	0.000577	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	7.36e-05	0.000575	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	7.09e-05	0.000555	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—type 1 diabetes mellitus	7.08e-05	0.000554	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—type 1 diabetes mellitus	6.78e-05	0.00053	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ITPR3—type 1 diabetes mellitus	6.75e-05	0.000528	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	6.37e-05	0.000498	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HBA1—type 1 diabetes mellitus	6.36e-05	0.000497	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOC3—type 1 diabetes mellitus	6.32e-05	0.000494	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	6.28e-05	0.000491	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—type 1 diabetes mellitus	6.21e-05	0.000485	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	6.19e-05	0.000484	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	5.99e-05	0.000469	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IAPP—type 1 diabetes mellitus	5.96e-05	0.000466	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOC3—type 1 diabetes mellitus	5.96e-05	0.000466	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—type 1 diabetes mellitus	5.74e-05	0.000449	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	5.7e-05	0.000446	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	5.62e-05	0.00044	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SST—type 1 diabetes mellitus	5.23e-05	0.000409	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	5.21e-05	0.000407	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCG—type 1 diabetes mellitus	4.94e-05	0.000387	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GCG—type 1 diabetes mellitus	4.66e-05	0.000364	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.49e-05	0.000351	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.36e-05	0.000341	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.35e-05	0.00034	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAT—type 1 diabetes mellitus	4.19e-05	0.000327	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.96e-05	0.00031	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.95e-05	0.000308	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD86—type 1 diabetes mellitus	3.8e-05	0.000297	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.63e-05	0.000284	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.61e-05	0.000282	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.43e-05	0.000268	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.37e-05	0.000263	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.32e-05	0.00026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.3e-05	0.000258	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INS—type 1 diabetes mellitus	2.78e-05	0.000217	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.77e-05	0.000217	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INS—type 1 diabetes mellitus	2.62e-05	0.000205	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—type 1 diabetes mellitus	2.55e-05	0.000199	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.53e-05	0.000198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.52e-05	0.000197	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—type 1 diabetes mellitus	2.44e-05	0.00019	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.34e-05	0.000183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.3e-05	0.00018	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.95e-05	0.000152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—type 1 diabetes mellitus	1.95e-05	0.000152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.94e-05	0.000151	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.64e-05	0.000128	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.49e-05	0.000116	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.14e-05	8.95e-05	CbGpPWpGaD
